Prevalence and Determinants of Chronic Pain Post-COVID; Cross-Sectional Study.
Panagiotis ZisChristiana IoannouArtemios ArtemiadisKaterina ChristodoulouStefania KalampokiniGeorgios M HadjigeorgiouPublished in: Journal of clinical medicine (2022)
Chronic pain-especially neuropathic-is widely prevalent in COVID-19 survivors. One in six subjects will develop new-onset pain that will persist beyond the acute phase of the disease and, therefore, should be considered a symptom of long COVID syndrome.